Filed in archive
Diagnostics, Methodologies and Instrumentation
, Genomics, Proteomics and Bioinformatics
by ruth on July 11, 2007
With the aim of guaranteeing safety during blood transfusions, Progenika has developed and validated 1,000 clinical samples in cooperation with the principal European blood banks. Concretely, the validation of these samples was 99.8%, considerably higher than that produced using the current serology technique, which produces an error of 3%.
The BLOODchip® is the result of research within the remit of the European Union IV Framework Programme and undertaken by Progenika in collaboration with the principal European blood banks.
Currently, BLOODchip® is the safest and most precise technique for genetically determining blood groups, enabling the reduction of adverse reactions in blood transfusions.
Find more details from the full report.
[Photo Credit: Progenika Biopharma]
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/79930
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for BLOODchip®: DNA Biochip That Ensures Safety in Blood Transfusions:
|
Rating: 7.00 out of 2 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
